Document is current
Any future updates will be listed below
-
Authors
Mulberg, Andrew E.
Bucci-Rechtweg, Christina
Giuliano, Joseph
Jacoby, David
Johnson, Franklin K.
Liu, Qing
Marsden, Deborah
McGoohan, Scott
Nelson, Robert
Patel, Nita
Romero, Klaus
Sinha, Vikram
Sitaraman, Sheela
Spaltro, John
Kessler, Vivian
-
Funding
Funding for this research was provided by:
Amicus Therapeutics, Inc (NA)
- License Information
-
More Information
Article History
Received: 28 November 2018
Accepted: 31 January 2019
First Online: 8 February 2019
Ethics approval and consent to participate
: NA
: All authors have seen and approved the manuscript.
: AEM, JG, FKJ, QL, NP, SS, JS, and VK are employees of and own stock in Amicus Therapeutics, Inc. CB-R is an employee of and owns stock in Novartis Pharmaceuticals Corporation. DJ is an employee of and owns stock in BioMarin Pharmaceutical, Inc. DM is an employee of and owns stock in Ultragenyx Pharmaceuticals, Inc. SM is an employee of and owns stock in Vertex Pharmaceuticals. RN is an employee of Johnson & Johnson. KR has nothing to disclose. VS is an employee of and owns stock in Merck & Co, Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
